Figure 6
Figure 6. Signaling pathways involved in the regulation of IDO1 expression and activity induced by IFNγ or LPS in HeLa cells and DCs. HeLa cells or DCs were treated with either IFN-γ or LPS with or without the inhibitors at the indicated concentrations for 2 days, and the cells were lysed and analyzed by Western blot using an anti-IDO or anti-GAPDH antibody. Representative data of 3 independent experiments are shown: IFN-γ–treated HeLa cells (A) and DCs (C), and LPS-treated DCs (E). Kyn levels in the supernatants from these treated cells were determined spectrophotometrically. Representative data of 3 independent experiments are used in the graphs: IFN-γ–treated HeLa cells (B) and DCs (D), and LPS-treated DCs (F). In panels A, C, and E, the vertical lines represent where 2 separate images were aligned. Error bars represent SD.

Signaling pathways involved in the regulation of IDO1 expression and activity induced by IFNγ or LPS in HeLa cells and DCs. HeLa cells or DCs were treated with either IFN-γ or LPS with or without the inhibitors at the indicated concentrations for 2 days, and the cells were lysed and analyzed by Western blot using an anti-IDO or anti-GAPDH antibody. Representative data of 3 independent experiments are shown: IFN-γ–treated HeLa cells (A) and DCs (C), and LPS-treated DCs (E). Kyn levels in the supernatants from these treated cells were determined spectrophotometrically. Representative data of 3 independent experiments are used in the graphs: IFN-γ–treated HeLa cells (B) and DCs (D), and LPS-treated DCs (F). In panels A, C, and E, the vertical lines represent where 2 separate images were aligned. Error bars represent SD.

Close Modal

or Create an Account

Close Modal
Close Modal